These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
484 related items for PubMed ID: 12143188
21. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens. Giannini E, Romagnoli P, Fasoli A, Chiarbonello B, Malfatti F, Botta F, Risso D, Lantieri PB, Savarino V, Testa R. Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345 [Abstract] [Full Text] [Related]
22. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer. Catalano F, Catanzaro R, Bentivegna C, Brogna A, Condorelli G, Cipolla R. Aliment Pharmacol Ther; 1998 Jan; 12(1):59-62. PubMed ID: 9692702 [Abstract] [Full Text] [Related]
26. [Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days]. Bujanda L, Sánchez A, Iriondo C, Santos A, Cosme A, Muñoz C. An Med Interna; 2001 Jul; 18(7):361-3. PubMed ID: 11534420 [Abstract] [Full Text] [Related]
27. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori. Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S. J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879 [Abstract] [Full Text] [Related]
31. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics. Wurzer H, Bardhan KD, Marcelino M, Jahnsen J, Allmaier M. Hepatogastroenterology; 2001 Nov; 48(42):1641-7. PubMed ID: 11813591 [Abstract] [Full Text] [Related]
32. Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. Perri F, Festa V, Clemente R, Villani MR, Quitadamo M, Caruso N, Bergoli ML, Andriulli A. Am J Gastroenterol; 2001 Jan; 96(1):58-62. PubMed ID: 11197288 [Abstract] [Full Text] [Related]
35. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases. Aydin A, Onder GF, Akarca US, Tekin F, Tunçyürek M, Musoğlu A. Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848 [Abstract] [Full Text] [Related]
36. Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial. Kaviani MJ, Malekzadeh R, Vahedi H, Sotoudeh M, Kamalian N, Amini M, Massarrat S. Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):915-9. PubMed ID: 11507355 [Abstract] [Full Text] [Related]
37. Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori. Smoot DT, Hinds T, Ashktorab H, Jagtap J, Kim KS, Scott VF. Am J Gastroenterol; 1999 Apr; 94(4):955-8. PubMed ID: 10201463 [Abstract] [Full Text] [Related]
38. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection. Zheng Q, Pan Y, Zhang L, Xiao SD. Chin J Dig Dis; 2005 Apr; 6(4):202-5. PubMed ID: 16246231 [Abstract] [Full Text] [Related]
39. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. Kamberoglou D, Polymeros D, Sanidas I, Doulgeroglou V, Savva S, Patra E, Tzias V. Aliment Pharmacol Ther; 2001 Sep; 15(9):1493-7. PubMed ID: 11552924 [Abstract] [Full Text] [Related]